AI System for Detection and Characterization of Chronic Enteropathies
Recruiting
Observational Study
Celiac Disease
Small Bowel Mucosal Atrophy or Lesions
Non-celiac Enteropathies
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 380 (estimated)
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Coeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter observational study aims to develop and validate an Artificial Intelligence (AI) system to detect and characterize small b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (age ≥18 years).
* Patients undergoing endoscopic investigation of the small bowel (endoscopy or capsule endoscopy)
Exclusion Criteria:
* Inability to provide informed consent.
Contacts